| Particulars |
|
|
|
|
Company Name
| Emcure Pharmaceuticals Ltd
|
Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
189.59 |
B.V. (₹) |
169.50 |
| Sales(₹ Cr.) |
4,381.92 |
NP (₹ Cr.) |
288.59 |
| NP Var% |
78.00 |
Div% |
30.00 |
| CPS(₹) |
27.10 |
EPS (₹) |
15.20 |
| Traded Value(₹ Lakhs) |
1,136.69 |
52 Week High |
1,673.00 |
| 52 Week Low |
890.00 |
Price BSE |
1,654.00 |
| Price NSE |
1,653.00 |
Market Capital (₹ Cr.) |
31,350.53 |
| P/C Ratio |
61.10 |
P/E Ratio |
108.70 |
| Price Vs.BV |
9.76 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
1,418.31 |
| NP(₹ Cr.) |
281.98 |
NP Var % |
462.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
3,847.63 |
| OPM |
13.55 |
NP |
232.25 |
| NP Var% |
210.29 |
EPS |
35.05 |
| PE |
47.18 |
|
|